Nomenclature
CAS number: 15686-71-2
(6
R,7
R)-7-[[(2
R)-Aminophenylacetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic
acid; 7-(
d-α-aminophenylacetamido)desacetoxycephalosporanic
acid; 7-(
d-2-amino-2-phenylacetamido)-3-methyl-Δ
3-cephem-4-carboxylic acid; Cefadros (Proter); Cefaloto (Lifepharma); Cefanex (Apothecon); Cefaseptin (Chassot); Cex (Nippon Glaxo); Derantel (Nippon Chemiphar); Efalexin (Maipe); Farexin (Lafare); Fergon 500 (Alfar); Garasin (Wakamoto); Ibilex (IBI); Iwalexin (Iwaki); Larixin (Toyama); Lexibiotico (Llano); Llonexina (Castillon); Madlexin (Meiji); Mamalexin (Showa Yakuhin); Mecilex (C.E.P.A.); Ohlexin (Ohta); Oracocin (Tobishi); Rinesal (Kissei); Sencephalin (Takeda); Sintolexyn (ISF-Italseber); Syncl (Toyo Jozo); Taicelexin (Taiyo); Tokiolexin (Isei); Xahl (SS Pharm.).
C
16H
17N
3O
4S; mol wt 347.39.
C 55.32%, H 4.93%, N 12.10%, O 18.42%, S 9.23%.
Description and references
Semi-synthetic cephalosporin antibiotic. Prepn:
R. B. Morin, B. G. Jackson, US 3275626; US 3507861 (1966, 1970 both to Lilly); Ryan et al., J. Med.
Chem. 12, 310 (1969). Pharmacology and toxicology:
Muggleton et al., Antimicrob.
Agents Chemother. 1968, 353; Kind et al., Welles et al., ibid. 361, 489. Comprehensive
description: L. P. Marrelli, Anal. Profiles
Drug Subs. 4, 21-46 (1975). Clinical pharmacology,
efficacy, adverse reactions: Postgrad. Med.
J. 59, Suppl. 5, 1-56 (1983).
Derivative
Monohydrate.
Nomenclature
CAS number: 23325-78-2
Cefa-Iskia (Iskia); Cefibacter (Rubio); Ceporex (GSK); Ceporexin (GSK); Keforal (Lilly); Keflet (Lilly); Keflex (Lilly); Oracef (Lilly); Ortisporina (Turro); Sartosona (Sastre); Servispor (Servipharm).
Properties
LD50 in mice, rats
(g/kg): 1.6-4.5, >5.0 orally; 0.4-1.3, >3.7 i.p. (Welles).Antibacterial.
Antibacterial.